Arizant Healthcare Inc. introduced its solution for helping keep clinicians warm and comfortable, the Solor vest, at the 2007 American Society of Anesthesiologists annual meeting in San Francisco, Oct. 14-17.

Mindray Medical International officially launched its upgraded PM8000 Express/PM9000 Express patient monitors in September and showed them off at the 2007 ASA meeting.

Arizant Healthcare Inc. released the Bair Hugger brand Spinal Underbody warming blanket at the American Society of Anesthesiologists (ASA) annual meeting in San Francisco Oct. 14-17.

Ultrasound maker ZONARE Medical Systems showcased its new z.one ultra mobile ultrasound system, the company's next-generation Convertible Ultrasound platform, at the 2007 ASA meeting.

During the 2007 ASA show GE Healthcare unveiled its newly FDA approved Navigator anesthesia software, which can monitor the patient’s ability to feel pain and offers advice when issues arise in the OR. The company also introduced its Pressure Controlled Ventilation-Volume Guaranteed (PCV-VG) technology in the Avance Carestation, an advanced anesthesia delivery solution, and featured one of its compact ultrasound systems, the LOGIQ e.

At the 2007 ASA Picis released its new version of CareSuite Extelligence Anesthesia version 3.0 software, which helps analyze and manage the business and clinical aspects of anesthesiology.
It integrates with the company’s Anesthesia manager AIMS system, allowing clinicians and business managers to access anesthesia information and recorded data.

October 18, 2007 - Covidien Ltd. and BioSynthema Inc. recently announced the signing of agreements to develop and commercialize a nuclear medicine therapy for neuroendocrine cancer patients.
Under the terms of an exclusive license agreement, BioSynthema will gain access to specific Covidien proprietary peptide technology. The license will enable BioSynthema to use this technology in conjunction with its own technology and proprietary clinical research to further develop a new targeted radionuclide therapy product.

October 18, 2007 - Researchers testing a vaccine based on the live bacteria Listeria, in women with advanced cervical cancer found it to be safe.
The Lovaxin C vaccine being developed by Advaxis Inc., is intended to treat cervical cancer and head and neck cancers that result from the human papilloma virus (HPV). This marked the first time the vaccine had been treated in humans.

October 18, 2007 - Lucid Inc.’s VivaNet telemedicine server and its VivaScope confocal imagers, which relies on using special microscopes to digitally image a patient’s skin, may bypass the need to surgically biopsy many patients.
The cellular resolution images may then be used by physicians to assist in forming a clinical judgment for a variety of skin conditions, including, for example, melanoma, basal cell carcinoma, actinic keratoses, and contact dermatitis.

October 18, 2007 – Interactive voice response solutions maker Vocantas Inc. recently announced general availability of Vocantas CallAssure, optimized for use in the healthcare environment.
The company says CallAssure uses advanced computer telephony and speech technology to enable clinics and hospitals to more easily monitor patients in the hopes of mitigating adverse effects that are common in recently discharged patients.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now